FGFR4 and breast cancer: FGFR4-induced genomic signature was also found to be predictive of organ-specific metastases (brain, liver, lung) in the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) breast cancer patient cohort independent of clinical subtype or stage [112].